The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder
Abstract
This study examines the relative effectiveness of cognitive behavior therapy (CBT) (ten sessions), fluoxetine (20 mg daily) and combined therapy (CBT plus fluoxetine) in women with premenstrual dysphoric disorder (PMDD). This was a randomized pragmatic treatment trial with three treatment cells. Treatment lasted for 6 months; a naturalistic follow-up was undertaken 1 year post-treatment. One hundred and eight women, satisfying the DSM-IV criteria for PMDD with 2 months' prospective confirmation were recruited into the study; sixty of these had completed 6 months of treatment and all measures before and after treatment. The main outcome measures were premenstrual scores on the Calendar of Premenstrual Experiences (COPE) and percentage of PMDD cases (DSM-IV diagnostic criteria). Significant improvement occurred in all three treatment-groups after 6 months' treatment, assessed by the COPE. Fluoxetine was associated with a more rapid improvement. There were no group differences in the percentage of DSM cases of PMDD post treatment, but at follow-up CBT was associated with better maintenance of treatment effects compared with fluoxetine. In conclusion, CBT and fluoxetine are equally effective treatments for PMDD, but the treatments have some differential effects that can be considered in treatment decisions. There appears to be no additional benefit of combining the treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The finding of significant differences across time when the groups are collapsed (ignoring the intervention group assignment), confirms previous reports [10, 13, 14] that taking part in an intervention for PMDs can reduce psychological premenstrual symptoms and premenstrual distress [15, 16, 18, 20, 72, 73].”
Citations
Cites
Cognitive behaviour therapy for the chronic fatigue syndrome: a randomised controlled trial.
Sharpe, M., Hawton, K., Simkin, S., Surawy, C., Hackmann, A., Klimes, I., Peto, T., Warrell, D., & Seagroatt, V. (1996) · BMJ · doi:10.1136/bmj.312.7022.22 · Cited by 528
Fluoxetine in the Treatment of Premenstrual Dysphoria
Steiner, M. S., Steinberg, S. I., Stewart, D. E., Carter, D., Berger, C., Reid, R. L., Grover, D., & Streiner, D. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506083322301 · Cited by 450
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
Dimmock, P. W., Wyatt, K. M., Jones, P. W., & O'Brien, P. S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02754-9 · Cited by 368
Mortola, J. F., GIRTON, L., Beck, L., & Yen, S. S. C. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90644-k · Cited by 220
Cognitive therapy for premenstrual syndrome
Blake, F., Salkovskis, P., Gath, D., Day, A., & Garrod, A. (1998) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(98)00042-7 · Cited by 196
David, A. S. (1993) · Psychological Medicine · doi:10.1017/s0033291700038782 · Cited by 194
TREATMENT OF SEVERE PREMENSTRUAL SYNDROME WITH OESTRADIOL PATCHES AND CYCLICAL ORAL NORETHISTERONE
Watson, N., Savvas, M., Studd, J. W. W., GARNETT, T. J., & Baber, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90784-8 · Cited by 193
Perimenstrual symptoms: prevalence and risk factors.
Logue, C. M., & Moos, R. H. (1986) · Psychosomatic Medicine · doi:10.1097/00006842-198607000-00002 · Cited by 178
Alleviation of premenstrual syndrome symptoms with the relaxation response.
Goodale, I. L., Domar, A. D., & Benson, H. (1990) · PubMed · Cited by 177
Treatment of Premenstrual Dysphoric Disorder With Sertraline During the Luteal Phase
Young, S. A., Hurt, P. H., Benedek, D. M., & Howard, R. S. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0206 · Cited by 136
Flagged first, then by citations
Research works printed but not linked: 3
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington 1994
- Hunter MS. Counseling in obstetrics and gynaecology. BPS Books, Leicester 1994
- 10.1080/10532528.1996.10559914 · DOI
Cited by
Sorted by citations
Items 101–127 of 127
Lambert, E. R., Nolan, L. N., & Schmalenberger, K. M. (2026) · British Journal of Clinical Psychology · doi:10.1111/bjc.70066 · Cited by 2
Premenstrual Disorders in Adolescents: An Updated Review
Rome, E. S., Kaznoch, D., & Issac, V. E. (2026) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2026.06.003 · Cited by 2
Nair, B. (2014) · Springer eBooks · doi:10.1007/978-3-319-11005-9_31 · Cited by 2
Mind over PMDD: A Glimpse into the Process of Pharmacotherapy-Psychotherapy Combination Treatment.
Nevo, G. A., & Nefsky, C. (2014) · Europe PMC (PubMed Central) · Cited by 2
Psychotherapy Modalities for Premenstrual Change: A Systematic Review
Buys, M. E. (2025) · Women & Therapy · doi:10.1080/02703149.2025.2534636 · Cited by 1
Diagnosis and Treatment of Premenstrual Syndrome
Anderson, Z. G. (2023) · Springer eBooks · doi:10.1007/978-3-031-14881-1_33 · Cited by 1
Prämenstruelle dysphorische Störung
Kühner, C., & Nayman, S. (2025) · Die Psychotherapie · doi:10.1007/s00278-025-00766-5 · Cited by 1
Frauenspezifische psychische Störungen in der Psychiatrie
Dorsch, V., & Rohde, A. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_89 · Cited by 1
Frauenspezifische psychische Störungen in der Psychiatrie
Dorsch, V., & Rohde, A. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_89-1 · Cited by 1
Ebrahim, S., Guyatt, G. H., Walter, S. D., Heels‐Ansdell, D., Bellman, M., Hanna, S., Patelis‐Siotis, I., & Busse, J. W. (2014) · PLoS ONE · doi:10.1371/annotation/fd8ade2b-e9ed-4f75-8e32-5b327535306c · Cited by 1
Frauenspezifische psychische Störungen in der Psychiatrie
Rohde, A. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_74
Wilhelmina and Manfreda at the Balcony (XIII century)
Campana, D. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.102004
Fluoxetina: profilo terapeutico e farmacoeconomico di un prodotto generico
Pepa, C. D., & Eandi, M. (2003) · Farmeconomia Health economics and therapeutic pathways · doi:10.7175/fe.v4i3.775
Dehkordi, M. A., Haghshenas, L., Alipoor, A., & Mohtashami, T. (2015) · Bimonthly Journal of Hormozgan University of Medical Sciences
Current Awareness in Human Psychopharmacology
(2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.459
Frauenspezifische psychische Störungen in der Psychiatrie
Rohde, A., & Dorsch, V. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_77
Diagnosis and Treatment of Premenstrual Syndrome
Anderson, Z. G. (2023) · Springer eBooks · doi:10.1007/978-3-319-17002-2_33-2
Application Status of Psychotherapy in Gynecology Field
牛, 梦. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361243
Management of Severe Premenstrual Syndrome (PMS)/Premenstrual Dysphoric Disorder (PMDD)
Panay, N. (2024) · ISGE series · doi:10.1007/978-3-031-55300-4_8
Premenstrual Disorders, Menstruation and Mental Health
Behrman, S., & Florio, A. D. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009689489.007
Zhu, X.-X., Zhao, S., Xu, Q., Tang, R., Lin-xia, X., Ye-jiang, Z., & Zhang, D.-Y. (2026) · World Journal of Psychiatry · doi:10.5498/wjp.117931
Tiwari, A., Lu, D., Chocano-Bedoya, P. O., & Bertone-Johnson, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00024-x
Buys, M. E., Peel, R., & Buiten, D. (2026) · Feminism & Psychology · doi:10.1177/09593535261464231
PREMENSTRUAL DYSPHORIC DISORDER (PMDD): CURRENT PHARMACOTHERAPY AND EMERGING TREATMENT APPROACHES
Oziębło, J., Kijowska, M., Klusek, K., Batory, M., Jakubowski, J., Kraska, K., Krasucka, N., Zynkowska, A., Skrzyniarz, A. M., & Kiełbus, M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6100
Premenstrual dysphoric disorder: Recognition and assessment
Seepana, S., & Allamsetty, S. (2026) · InnovAiT Education and inspiration for general practice · doi:10.1177/17557380261478524
Metadata
- Authors
- Hunter, M. S., Ussher, J. M., Browne, S. J., Cariss, M., Jelley, R., & Katz, M.
- Affiliations
- Guy's Hospital (GB)
- Western Sydney University (AU)
- University College London (GB)
- University College Hospital (GB)
- Corresponding author
- Hunter, M. S.
- Venue
- Journal of Psychosomatic Obstetrics & Gynecology
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 23
- Issue
- 3
- Pages
- 193-199
- ISSN
- 0167-482X (ISSN-L)
- 1743-8942
- OpenAlex
- W2100718469
- Cited by
- 128
- References
- 27
- Citations by year
- 2026: 8 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 8 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 1 · 2017: 8 · 2016: 5 · 2015: 9 · 2014: 8 · 2013: 6 · 2012: 4
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychosomatic Obstetrics & Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- premenstrual dysphoric disorder, cognitive behavioral therapy, fluoxetine, treatment effectiveness, maintenance of treatment effects, women's mental health
- MeSH terms
- Adult, Analysis of Variance, Combined Modality Therapy, Female, Fluoxetine, Humans, London, Middle Aged, Premenstrual Syndrome, Cognitive Behavioral Therapy, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review